Two statements

TeaCrine And A Label That Says No Stimulants

Reviewed by Dr. Elena Christofides, MD, FACE

A feature strip that says No Stimulants and an ingredient list that names TeaCrine. Both belong to the seller, and without an amount neither can be settled.

Two statements from one seller

The seller’s feature strip lists six marks for the formula: natural formula, plant ingredients, non-GMO, easy to swallow, no stimulants and non-habit forming. The ingredient list, on the same material, names TeaCrine.

Both are the seller’s statements rather than this desk’s — and this article prints them together because a reader who avoids stimulants deserves to see them in the same place. Nothing here accuses anyone of anything. The two lines simply sit badly together, and the figure that would settle them is not published.

TeaCrine is a trade name; theacrine is a compound

TeaCrine is a branded ingredient. Theacrine is the molecule inside it, 1,3,7,9-tetramethyluric acid, a purine alkaloid found in kucha tea and cupuaçu. Caffeine is 1,3,7-trimethylxanthine, from the same broad family, which is why the two are repeatedly studied side by side.

Keeping the two words apart matters more than it looks. A paper on theacrine is evidence about the molecule — not about a particular branded powder, its purity, or the amount inside a capsule that publishes none. Everything below is about theacrine, the compound sold under the TeaCrine name, and the article on the six names explains why a branded name is the hardest kind to check.

Why a branded name is harder to research

A buyer who reads “theacrine” can search for it. A buyer who reads “TeaCrine” searches a trademark and finds a supplier’s page first. That is not unique to this label, and it is one of the reasons a named list is worth reading name by name rather than glancing at.

What the human trials measured

Two human studies of theacrine on its own are worth knowing, and both are safety and performance work rather than metabolic work.

Taylor and colleagues, 2016 gave 60 adults 200 mg or 300 mg a day for eight weeks and reported every clinical safety marker within normal limits, with no habituation across the period. Ziegenfuss and colleagues, 2017 used 200 mg and 400 mg a day for seven days and then a single 200 mg dose in a placebo-controlled crossover. Subjective energy, focus and concentration went up; there was no dose-response between 200 mg and 400 mg; and resting heart rate and haemodynamic measures did not change.

Both trials tested theacrine on its own, which is why they are cited here. A third study often quoted for this ingredient tested it alongside 150 mg of caffeine, so it cannot support a statement about theacrine by itself.

The blood glucose claim, and what sits behind it

The seller’s own line for this ingredient is that TeaCrine “supports healthy blood glucose metabolism”, alongside claims about cognition, focus, mood and mental energy.

A search of the published human literature for theacrine with blood glucose outcomes returns no records. Not a weak trial, not a mixed result — no human trial of this compound has measured blood glucose at all. That is the plainest sentence in this article and the one worth carrying away.

So of the four things the seller says about this ingredient, the two that human trials have looked at are energy and focus, and those were self-reported. The blood glucose line has no human trial behind it, which is a different situation from an ingredient whose trials came out badly. The how-it-works page covers the same ground for the formula as a whole.

Can the two statements be reconciled?

Possibly — though not from the label. There is a version of this formula in which TeaCrine is present at a few milligrams, produces nothing anyone would call a stimulant effect, and the feature strip is defensible. There is another in which it sits near the studied range and the strip is not. The whole blend is 525 mg, which rules nothing out at either end.

One number would settle it, and it is the number a Supplement Facts panel would have carried.

One of five. That is why this desk prints both of the seller’s statements and settles neither, and why the label page keeps the blank lines blank.

What a supplement label is allowed to say

Three public rules explain the shape of every sentence on a bottle like this, and they are worth a paragraph each because they make marketing copy much easier to read.

Structure/function claims are statements about an effect on a normal structure or function of the body. A manufacturer may make one without pre-approval, has to notify the FDA within 30 days, and must carry the disclaimer saying the statement has not been evaluated and the product is not intended to diagnose, treat, cure or prevent any disease, because only a drug can legally make such a claim.

21 CFR 101.93 sets that disclaimer’s exact wording and draws the line: a product bearing a disease claim is subject to regulation as a drug. And the FTC’s health products guidance governs the advertising rather than the label, asking for competent and reliable scientific evidence, generally randomised controlled human trials, and requiring that any claim about the level of that support is itself true.

Held against those three, a no-stimulants feature mark is not a regulated claim at all. It is a marketing statement about the formula, and the only thing that could verify it is the formula.

Who this entry actually matters to

For most buyers this is a footnote. For four groups it is the deciding line on the label, and they are the reason the entry is worth an article.

• Anyone who avoids caffeine and caffeine-like compounds on purpose, for sleep, anxiety, palpitations or a clinician’s advice.
• Anyone taking it before breakfast, which is the seller’s own direction: one capsule in the morning, before breakfast, with a glass of water. An alkaloid on an empty stomach is a different experience from one with food.
• Anyone already using a pre-workout or an energy product. Branded alkaloids appear across that category, and two products can stack without either one printing a total.
• Anyone whose reason for buying is the four claims on the front. The benefits page sets out what those four lines cover and what they do not.

The verdict on this entry

TeaCrine is the entry a careful reader should look at hardest — and the reason is not safety. The two human trials of theacrine on its own reported clinical markers within normal limits at 200 to 300 mg a day for eight weeks and no change in resting heart rate. It is the reconciliation that fails, not the ingredient.

A feature strip that says no stimulants and an ingredient list that names a caffeine-comparator alkaloid cannot both be checked without a milligram figure, and there is not one. If stimulants are the thing you are screening for, that is the answer: the label names the entry, which is more than most, and it does not tell you how much. Who it is for goes through the same decision for the formula as a whole, and the guarantee is what covers a first bottle either way.